Companion Animals

Cat Feline Immune Disease Management: Long-Term Welfare

Immune-mediated diseases in cats require long-term management with welfare assessment guiding treatment intensity.

Key Facts

Immune polyarthritis, IMHA, and immune thrombocytopenia are common feline immune diseases
Immunosuppressive treatment with prednisolone and ciclosporin controls most immune diseases
Secondary infections during immunosuppression are a welfare risk requiring monitoring
Quality of life assessment guides treatment intensity - side effects must be weighed against disease control

Welfare Considerations

Long-term immunosuppressive treatment controls immune diseases but introduces secondary welfare risks from infection susceptibility and drug side effects. Monitoring that assesses welfare impact of treatment alongside disease control guides appropriate dose management. Welfare-optimal management may differ from maximum immunosuppression.

What You Can Do

Monitor for infection signs during immunosuppressive treatment - report any to your vet promptly
Use quality of life assessment tools to evaluate whether treatment intensity is appropriate
Request regular blood monitoring during immunosuppressive therapy to detect secondary effects